Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel

1. In the present study, the properties of glaucine (an aporphine structurally related to papaverine) were compared with those of papaverine, diltiazem, nifedipine and prazosin. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determina...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 1992-06, Vol.106 (2), p.387-394
Hauptverfasser: Ivorra, M D, Lugnier, C, Schott, C, Catret, M, Noguera, M A, Anselmi, E, D'Ocon, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 394
container_issue 2
container_start_page 387
container_title British journal of pharmacology
container_volume 106
creator Ivorra, M D
Lugnier, C
Schott, C
Catret, M
Noguera, M A
Anselmi, E
D'Ocon, P
description 1. In the present study, the properties of glaucine (an aporphine structurally related to papaverine) were compared with those of papaverine, diltiazem, nifedipine and prazosin. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determination of the affinity of glaucine at calcium channel binding sites of alpha-adrenoceptors, by use of [3H]-(+)-cis-diltiazem, [3H]-nitrendipine and [3H]-prazosin binding to cerebral cortical membranes. The effects of glaucine on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were also determined. 2. Contraction evoked by noradrenaline (1 microM) or depolarizing solution (60 mM KCl) were inhibited in a concentration-dependent manner by all the compounds tested. As expected, prazosin showed a greater selectivity of action on NA-induced contraction, whereas nifedipine and diltiazem appeared more potent on KCl-induced contraction. Glaucine had a greater potency on the contraction elicited by noradrenaline whereas papaverine acted non specifically. 3. In Ca(2+)-free solution, prazosin (0.1 microM) and glaucine (0.1 mM) inhibited the contraction evoked by NA; diltiazem (0.1 mM) diminished this contraction whereas nifedipine (1 microM) had no effect. Preincubation of tissues with glaucine, diltiazem, nifedipine and prazosin did not modify the contractile response induced by caffeine. In contrast, papaverine (0.1 mM) significantly inhibited the contractions evoked by NA or caffeine in Ca(2+)-free medium. 4. Glaucine and papaverine show affinity at the [3H]-prazosin binding site and at the benzothiazepine binding site of the Ca(2+)-channel receptor complex, but have no effect at the dihydropyridine binding site in rat cerebral cortex. Glaucine exerts some selectivity as an inhibitor of [3H]-prazosin binding as opposed to [3H]-(+ )-cis-diltiazem binding while papaverine appears to have approximately equal affinity in this respect.5. This study confirms the presence of four phosphodiesterase (PDE) activities in bovine aorta: a calmodulin-activated PDE (CaM-PDE type I) which hydrolyzed preferentially guanosine 3':5'-cyclic monophosphate (cyclic GMP); a cyclic GMP selective form (cGMP-PDE type V); and two low Km adenosine 3':5'-cyclic monophosphate (cyclic AMP) PDEs that are insensitive to the stimulatory effect of CaM, one of which was inhibited by cyclic GMP (CGI-PDE, type III) and the other by rolipram (cAMP-PDE, type
doi_str_mv 10.1111/j.1476-5381.1992.tb14345.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1907502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73226269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-fe1310b965375e9370948728de1cbf2179930edec74da78db108e9742adc536c3</originalsourceid><addsrcrecordid>eNpVkV2L1TAQhoMo63H1JwjBC69szUfbNF4IsvgFK97odUiT6WkOOUlN0mV3f4a_2JZzWHVgmIt35p1hHoReUVLTNd4eatqIrmp5T2sqJavLQBvetPXtI7R7kB6jHSFEVJT2_VP0LOcDIaso2gt0QTkTvCc79Pvb4oubPWBtiosh4zjivdeLcQFwDNjcGe8MDovxEIuzgOcp5jWtg1wg6Qz5DdZ-njSmlbYJQjQwl5iwDhYPEO5jmZy-h3lzHFywLuxxdmVdWXCZABvtjVuO2Ew6BPDP0ZNR-wwvzvUS_fz08cfVl-r6--evVx-uK8MJLdUIlFMyyK7logXJBZFNL1hvgZphZFRIyQlYMKKxWvR2oKQHKRqmrWl5Z_glen_ynZfhCNZAKEl7NSd31OlORe3U_0pwk9rHG0UlES1hq8Hrs0GKv5b1G-rosgHvdYC4ZCU4Yx3r5Nr47tRoUsw5wfiwhBK1EVUHtWFTGza1EVVnoup2HX7575l_R08I-R9ea6ML</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73226269</pqid></control><display><type>article</type><title>Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ivorra, M D ; Lugnier, C ; Schott, C ; Catret, M ; Noguera, M A ; Anselmi, E ; D'Ocon, P</creator><creatorcontrib>Ivorra, M D ; Lugnier, C ; Schott, C ; Catret, M ; Noguera, M A ; Anselmi, E ; D'Ocon, P</creatorcontrib><description>1. In the present study, the properties of glaucine (an aporphine structurally related to papaverine) were compared with those of papaverine, diltiazem, nifedipine and prazosin. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determination of the affinity of glaucine at calcium channel binding sites of alpha-adrenoceptors, by use of [3H]-(+)-cis-diltiazem, [3H]-nitrendipine and [3H]-prazosin binding to cerebral cortical membranes. The effects of glaucine on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were also determined. 2. Contraction evoked by noradrenaline (1 microM) or depolarizing solution (60 mM KCl) were inhibited in a concentration-dependent manner by all the compounds tested. As expected, prazosin showed a greater selectivity of action on NA-induced contraction, whereas nifedipine and diltiazem appeared more potent on KCl-induced contraction. Glaucine had a greater potency on the contraction elicited by noradrenaline whereas papaverine acted non specifically. 3. In Ca(2+)-free solution, prazosin (0.1 microM) and glaucine (0.1 mM) inhibited the contraction evoked by NA; diltiazem (0.1 mM) diminished this contraction whereas nifedipine (1 microM) had no effect. Preincubation of tissues with glaucine, diltiazem, nifedipine and prazosin did not modify the contractile response induced by caffeine. In contrast, papaverine (0.1 mM) significantly inhibited the contractions evoked by NA or caffeine in Ca(2+)-free medium. 4. Glaucine and papaverine show affinity at the [3H]-prazosin binding site and at the benzothiazepine binding site of the Ca(2+)-channel receptor complex, but have no effect at the dihydropyridine binding site in rat cerebral cortex. Glaucine exerts some selectivity as an inhibitor of [3H]-prazosin binding as opposed to [3H]-(+ )-cis-diltiazem binding while papaverine appears to have approximately equal affinity in this respect.5. This study confirms the presence of four phosphodiesterase (PDE) activities in bovine aorta: a calmodulin-activated PDE (CaM-PDE type I) which hydrolyzed preferentially guanosine 3':5'-cyclic monophosphate (cyclic GMP); a cyclic GMP selective form (cGMP-PDE type V); and two low Km adenosine 3':5'-cyclic monophosphate (cyclic AMP) PDEs that are insensitive to the stimulatory effect of CaM, one of which was inhibited by cyclic GMP (CGI-PDE, type III) and the other by rolipram (cAMP-PDE, type IV). Glaucine selectively inhibits one of the two forms of Ca2+-independent low Km cAMP-PDE, the type IV. In contrast, papaverine exerts a non-selective inhibitory effect upon all PDE forms.6. The present work provides evidence that glaucine, a benzyltetrahydroisoquinoline alkaloid, has interesting properties as an alpha l-adrenoceptor antagonist, calcium entry blocker (through the benzothiazepine recognition site in the calcium channel) and as a selective inhibitor of the rolipram-sensitive cAMP-PDE, type IV PDE.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1992.tb14345.x</identifier><identifier>PMID: 1327380</identifier><language>eng</language><publisher>England</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - metabolism ; Animals ; Aorta, Thoracic - drug effects ; Aorta, Thoracic - metabolism ; Aporphines - pharmacology ; Binding, Competitive - drug effects ; Calcium Channels - drug effects ; Calcium Channels - metabolism ; Cattle ; In Vitro Techniques ; Male ; Muscle Contraction - drug effects ; Muscle, Smooth, Vascular - drug effects ; Norepinephrine - metabolism ; Phosphodiesterase Inhibitors - pharmacology ; Prazosin - metabolism ; Radioligand Assay ; Rats ; Rats, Wistar ; Receptors, Adrenergic, alpha - metabolism</subject><ispartof>British journal of pharmacology, 1992-06, Vol.106 (2), p.387-394</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-fe1310b965375e9370948728de1cbf2179930edec74da78db108e9742adc536c3</citedby><cites>FETCH-LOGICAL-c301t-fe1310b965375e9370948728de1cbf2179930edec74da78db108e9742adc536c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907502/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907502/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1327380$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivorra, M D</creatorcontrib><creatorcontrib>Lugnier, C</creatorcontrib><creatorcontrib>Schott, C</creatorcontrib><creatorcontrib>Catret, M</creatorcontrib><creatorcontrib>Noguera, M A</creatorcontrib><creatorcontrib>Anselmi, E</creatorcontrib><creatorcontrib>D'Ocon, P</creatorcontrib><title>Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1. In the present study, the properties of glaucine (an aporphine structurally related to papaverine) were compared with those of papaverine, diltiazem, nifedipine and prazosin. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determination of the affinity of glaucine at calcium channel binding sites of alpha-adrenoceptors, by use of [3H]-(+)-cis-diltiazem, [3H]-nitrendipine and [3H]-prazosin binding to cerebral cortical membranes. The effects of glaucine on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were also determined. 2. Contraction evoked by noradrenaline (1 microM) or depolarizing solution (60 mM KCl) were inhibited in a concentration-dependent manner by all the compounds tested. As expected, prazosin showed a greater selectivity of action on NA-induced contraction, whereas nifedipine and diltiazem appeared more potent on KCl-induced contraction. Glaucine had a greater potency on the contraction elicited by noradrenaline whereas papaverine acted non specifically. 3. In Ca(2+)-free solution, prazosin (0.1 microM) and glaucine (0.1 mM) inhibited the contraction evoked by NA; diltiazem (0.1 mM) diminished this contraction whereas nifedipine (1 microM) had no effect. Preincubation of tissues with glaucine, diltiazem, nifedipine and prazosin did not modify the contractile response induced by caffeine. In contrast, papaverine (0.1 mM) significantly inhibited the contractions evoked by NA or caffeine in Ca(2+)-free medium. 4. Glaucine and papaverine show affinity at the [3H]-prazosin binding site and at the benzothiazepine binding site of the Ca(2+)-channel receptor complex, but have no effect at the dihydropyridine binding site in rat cerebral cortex. Glaucine exerts some selectivity as an inhibitor of [3H]-prazosin binding as opposed to [3H]-(+ )-cis-diltiazem binding while papaverine appears to have approximately equal affinity in this respect.5. This study confirms the presence of four phosphodiesterase (PDE) activities in bovine aorta: a calmodulin-activated PDE (CaM-PDE type I) which hydrolyzed preferentially guanosine 3':5'-cyclic monophosphate (cyclic GMP); a cyclic GMP selective form (cGMP-PDE type V); and two low Km adenosine 3':5'-cyclic monophosphate (cyclic AMP) PDEs that are insensitive to the stimulatory effect of CaM, one of which was inhibited by cyclic GMP (CGI-PDE, type III) and the other by rolipram (cAMP-PDE, type IV). Glaucine selectively inhibits one of the two forms of Ca2+-independent low Km cAMP-PDE, the type IV. In contrast, papaverine exerts a non-selective inhibitory effect upon all PDE forms.6. The present work provides evidence that glaucine, a benzyltetrahydroisoquinoline alkaloid, has interesting properties as an alpha l-adrenoceptor antagonist, calcium entry blocker (through the benzothiazepine recognition site in the calcium channel) and as a selective inhibitor of the rolipram-sensitive cAMP-PDE, type IV PDE.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</subject><subject>Animals</subject><subject>Aorta, Thoracic - drug effects</subject><subject>Aorta, Thoracic - metabolism</subject><subject>Aporphines - pharmacology</subject><subject>Binding, Competitive - drug effects</subject><subject>Calcium Channels - drug effects</subject><subject>Calcium Channels - metabolism</subject><subject>Cattle</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Norepinephrine - metabolism</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Prazosin - metabolism</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Adrenergic, alpha - metabolism</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV2L1TAQhoMo63H1JwjBC69szUfbNF4IsvgFK97odUiT6WkOOUlN0mV3f4a_2JZzWHVgmIt35p1hHoReUVLTNd4eatqIrmp5T2sqJavLQBvetPXtI7R7kB6jHSFEVJT2_VP0LOcDIaso2gt0QTkTvCc79Pvb4oubPWBtiosh4zjivdeLcQFwDNjcGe8MDovxEIuzgOcp5jWtg1wg6Qz5DdZ-njSmlbYJQjQwl5iwDhYPEO5jmZy-h3lzHFywLuxxdmVdWXCZABvtjVuO2Ew6BPDP0ZNR-wwvzvUS_fz08cfVl-r6--evVx-uK8MJLdUIlFMyyK7logXJBZFNL1hvgZphZFRIyQlYMKKxWvR2oKQHKRqmrWl5Z_glen_ynZfhCNZAKEl7NSd31OlORe3U_0pwk9rHG0UlES1hq8Hrs0GKv5b1G-rosgHvdYC4ZCU4Yx3r5Nr47tRoUsw5wfiwhBK1EVUHtWFTGza1EVVnoup2HX7575l_R08I-R9ea6ML</recordid><startdate>199206</startdate><enddate>199206</enddate><creator>Ivorra, M D</creator><creator>Lugnier, C</creator><creator>Schott, C</creator><creator>Catret, M</creator><creator>Noguera, M A</creator><creator>Anselmi, E</creator><creator>D'Ocon, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199206</creationdate><title>Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel</title><author>Ivorra, M D ; Lugnier, C ; Schott, C ; Catret, M ; Noguera, M A ; Anselmi, E ; D'Ocon, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-fe1310b965375e9370948728de1cbf2179930edec74da78db108e9742adc536c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - metabolism</topic><topic>Animals</topic><topic>Aorta, Thoracic - drug effects</topic><topic>Aorta, Thoracic - metabolism</topic><topic>Aporphines - pharmacology</topic><topic>Binding, Competitive - drug effects</topic><topic>Calcium Channels - drug effects</topic><topic>Calcium Channels - metabolism</topic><topic>Cattle</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Norepinephrine - metabolism</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Prazosin - metabolism</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Adrenergic, alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivorra, M D</creatorcontrib><creatorcontrib>Lugnier, C</creatorcontrib><creatorcontrib>Schott, C</creatorcontrib><creatorcontrib>Catret, M</creatorcontrib><creatorcontrib>Noguera, M A</creatorcontrib><creatorcontrib>Anselmi, E</creatorcontrib><creatorcontrib>D'Ocon, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivorra, M D</au><au>Lugnier, C</au><au>Schott, C</au><au>Catret, M</au><au>Noguera, M A</au><au>Anselmi, E</au><au>D'Ocon, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1992-06</date><risdate>1992</risdate><volume>106</volume><issue>2</issue><spage>387</spage><epage>394</epage><pages>387-394</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>1. In the present study, the properties of glaucine (an aporphine structurally related to papaverine) were compared with those of papaverine, diltiazem, nifedipine and prazosin. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determination of the affinity of glaucine at calcium channel binding sites of alpha-adrenoceptors, by use of [3H]-(+)-cis-diltiazem, [3H]-nitrendipine and [3H]-prazosin binding to cerebral cortical membranes. The effects of glaucine on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were also determined. 2. Contraction evoked by noradrenaline (1 microM) or depolarizing solution (60 mM KCl) were inhibited in a concentration-dependent manner by all the compounds tested. As expected, prazosin showed a greater selectivity of action on NA-induced contraction, whereas nifedipine and diltiazem appeared more potent on KCl-induced contraction. Glaucine had a greater potency on the contraction elicited by noradrenaline whereas papaverine acted non specifically. 3. In Ca(2+)-free solution, prazosin (0.1 microM) and glaucine (0.1 mM) inhibited the contraction evoked by NA; diltiazem (0.1 mM) diminished this contraction whereas nifedipine (1 microM) had no effect. Preincubation of tissues with glaucine, diltiazem, nifedipine and prazosin did not modify the contractile response induced by caffeine. In contrast, papaverine (0.1 mM) significantly inhibited the contractions evoked by NA or caffeine in Ca(2+)-free medium. 4. Glaucine and papaverine show affinity at the [3H]-prazosin binding site and at the benzothiazepine binding site of the Ca(2+)-channel receptor complex, but have no effect at the dihydropyridine binding site in rat cerebral cortex. Glaucine exerts some selectivity as an inhibitor of [3H]-prazosin binding as opposed to [3H]-(+ )-cis-diltiazem binding while papaverine appears to have approximately equal affinity in this respect.5. This study confirms the presence of four phosphodiesterase (PDE) activities in bovine aorta: a calmodulin-activated PDE (CaM-PDE type I) which hydrolyzed preferentially guanosine 3':5'-cyclic monophosphate (cyclic GMP); a cyclic GMP selective form (cGMP-PDE type V); and two low Km adenosine 3':5'-cyclic monophosphate (cyclic AMP) PDEs that are insensitive to the stimulatory effect of CaM, one of which was inhibited by cyclic GMP (CGI-PDE, type III) and the other by rolipram (cAMP-PDE, type IV). Glaucine selectively inhibits one of the two forms of Ca2+-independent low Km cAMP-PDE, the type IV. In contrast, papaverine exerts a non-selective inhibitory effect upon all PDE forms.6. The present work provides evidence that glaucine, a benzyltetrahydroisoquinoline alkaloid, has interesting properties as an alpha l-adrenoceptor antagonist, calcium entry blocker (through the benzothiazepine recognition site in the calcium channel) and as a selective inhibitor of the rolipram-sensitive cAMP-PDE, type IV PDE.</abstract><cop>England</cop><pmid>1327380</pmid><doi>10.1111/j.1476-5381.1992.tb14345.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1992-06, Vol.106 (2), p.387-394
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1907502
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects 3',5'-Cyclic-AMP Phosphodiesterases - metabolism
Animals
Aorta, Thoracic - drug effects
Aorta, Thoracic - metabolism
Aporphines - pharmacology
Binding, Competitive - drug effects
Calcium Channels - drug effects
Calcium Channels - metabolism
Cattle
In Vitro Techniques
Male
Muscle Contraction - drug effects
Muscle, Smooth, Vascular - drug effects
Norepinephrine - metabolism
Phosphodiesterase Inhibitors - pharmacology
Prazosin - metabolism
Radioligand Assay
Rats
Rats, Wistar
Receptors, Adrenergic, alpha - metabolism
title Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A11%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20actions%20of%20glaucine%20on%20cyclic%20nucleotide%20phosphodiesterases,%20alpha%201-adrenoceptor%20and%20benzothiazepine%20binding%20site%20at%20the%20calcium%20channel&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Ivorra,%20M%20D&rft.date=1992-06&rft.volume=106&rft.issue=2&rft.spage=387&rft.epage=394&rft.pages=387-394&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/j.1476-5381.1992.tb14345.x&rft_dat=%3Cproquest_pubme%3E73226269%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73226269&rft_id=info:pmid/1327380&rfr_iscdi=true